Recent Developments on Ionic Liquids and Deep Eutectic Solvents for Drug Delivery Applications
- PMID: 35739370
- DOI: 10.1007/s11095-022-03315-w
Recent Developments on Ionic Liquids and Deep Eutectic Solvents for Drug Delivery Applications
Abstract
The field of Ionic liquids (ILs) and deep eutectic solvents (DESs) is continuously expanding due to their exceptional unique properties and highly tunable nature, which finds applications in broad areas of modern science. Considering numerous possible IL and DES combinations prepared with active pharmaceutical ingredients (APIs), they find applications in pharmaceutical sciences. They can also serve as potential components of drug formulations and hence they have drawn the attention of formulation scientists. Herein, the concept of pharmaceutical ILs and DESs are discussed briefly. The possible applications of these solvent systems for slow drug delivery including nanoscale drug delivery are discussed citing various examples from the published literature. Although the ILs and DESs are found to be suitable for various drug delivery applications but still none of the slow drug delivery vehicles based on these solvents is in practical use. The data relating to long-term toxicity upon administration in the human body followed by various safety evaluations, clinical trials, etc. are pending for such new drug delivery systems. However, proof of concept studies done on the retention of biological activities in the ionic form is quite encouraging and such studies indicate the possibility of application of such new systems in the development of biomedical research and related industries in near future.
Keywords: deep eutectic solvents; drug delivery; ionic liquids; pharmaceuticals.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11(3):191–200. https://doi.org/10.1038/nrd3681 . - DOI - PubMed
-
- Shamshina JL, Kelley SP, Gurau G, Rogers RD. Chemistry: develop ionic liquid drugs. Nature. 2015;528(7581):188–9. https://doi.org/10.1038/528188a . - DOI - PubMed
-
- Hussan KS, Thayyil MS, Deshpande SK, Jinitha TV, Rajan VK, Ngai KL. Synthesis and molecular dynamics of double active pharmaceutical ingredient-benzalkonium ibuprofenate. J Mol Liq. 2016;223:1333–9. https://doi.org/10.1016/j.molliq.2016.09.054 . - DOI
-
- Sareen S, Mathew G, Joseph L. Improvement in solubility of poor water-soluble drugs by solid dispersion. International Journal of Pharmaceutical Investigation. 2012;2(1):12. https://doi.org/10.4103/2230-973X.96921 . - DOI - PubMed - PMC
-
- Santos de Almeida T, Júlio A, Saraiva N, Fernandes AS, Araújo ME, Baby AR, Rosado C, Mota JP. Choline-versus imidazole-based ionic liquids as functional ingredients in topical delivery systems: cytotoxicity, solubility, and skin permeation studies. Drug Dev Ind Pharm. 2017;43(11):1858–65. https://doi.org/10.1080/03639045.2017.1349788 . - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources